ABOUT DICLOFENAC SODIUM

Gastrointestinal (GI): NSAIDs that block COX-one action have correlations with GI complications as a result of inhibition with the synthesis of gastroprotective brokers like PGE2 as well as other prostaglandins. This inhibition causes lessened mucin output by gastric epithelial cells, a lot less bicarbonate secretion, and less epithelial cell turno

Gastrointestinal (GI): NSAIDs that block COX-1 exercise have correlations with GI complications a result of the inhibition of the synthesis of gastroprotective brokers for instance PGE2 along with other prostaglandins. This inhibition leads to lessened mucin production by gastric epithelial cells, fewer bicarbonate secretion, and less epithelial mo